The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.
 
Donald Smith
Employment - MedStar Health; Georgetown University Medical Cent
Research Funding - Kailos Genetics, Inc. (Inst)
 
Ilana Schlam
No Relationships to Disclose
 
Cody Peer
Employment - Amgen
 
Tristan Sissung
No Relationships to Disclose
 
Keith Thomas Schmidt
No Relationships to Disclose
 
Ming Tony Tan
Honoraria - AstraZeneca; Incyce; Otsuka; Sanofi Pasteur
Consulting or Advisory Role - American Gene Technologies
Research Funding - Genentech
 
Ami Chitalia
Honoraria - ASCO
Consulting or Advisory Role - ASCO
 
Nanette H. Bishopric
Leadership - Seagen (I)
Stock and Other Ownership Interests - Gilead Sciences; Lilly; Lilly; Pfizer; Seagen; Seagen (I)
Consulting or Advisory Role - Catena (I)
 
Seth M. Steinberg
No Relationships to Disclose
 
Hyoyoung Choo-Wosoba
No Relationships to Disclose
 
Christopher Gallagher
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo; Lilly; Pfizer
Speakers' Bureau - Daiichi Sankyo/UCB Japan
 
Nadia Ashai
No Relationships to Disclose
 
Kristen Danielle Whitaker
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Biotheranostics
 
Candace Bavette Mainor
Research Funding - cantex (Inst); Pfizer (Inst)
 
Shruti Rakesh Tiwari
No Relationships to Disclose
 
Nicole Swanson
No Relationships to Disclose
 
Stacy K Malloy
No Relationships to Disclose
 
Claudine Isaacs
Honoraria - Pfizer; Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Curio/Vaniam Group; Medscape; MJH/PER; Side-Out Foundation
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Sandra M. Swain
Leadership - Seagen; Seagen
Stock and Other Ownership Interests - SEAGEN
Honoraria - Chugai/Roche
Consulting or Advisory Role - AstraZeneca; Aventis Pharma; Daiichi Sankyo; Genentech/Roche; Jaguar Health; Molecular Templates
Travel, Accommodations, Expenses - Aventis Pharma; Chugai/Roche; Daichi Sankyo; Genentech/Roche
Other Relationship - AstraZeneca; Roche
(OPTIONAL) Uncompensated Relationships - Genentech/Roche